Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Diabetic neovascularization refers to a type of diabetic retinopathy which is worsening by
the abnormal growth of blood vessels in the back of the eye, damaging the retina. The usual
treatment is a type of laser, called panretinal photocoagulation. One drawback is that the
amount of space within the eye for use of this treatment eventually has its limit, and should
not be used too near the part of the retina used for detailed vision (the macula). In similar
eye disorders, there are certain injectable medications called anti-VEGF treatments which can
slow down or stop this abnormal blood vessel growth. This study sought to compare use of
ranibizumab versus standard panretinal photocoagulation in treatment of diabetic
neovascularization.